chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Neuropathic itching; Burning itch; This case was reported by a consumer and described the occurrence of itch burning in a 70-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included gastroesophageal reflux disease. Concomitant products included pantoprazole.   On 1st August 2021, the patient received Shingles vaccine. On 1st January 2022, 153 days after receiving Shingles vaccine, the patient experienced itch burning. On an unknown date, the patient experienced neuropathic itching. On an unknown date, the outcome of the itch burning was not recovered/not resolved and the outcome of the neuropathic itching was unknown.   It was unknown if the reporter considered the itch burning and neuropathic itching to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-Feb-2023 Reporter comment: This case was self-reported by the patient. The patient experienced burning itch and it was ongoing. The burning itch symptoms were treated. The patient would appreciate the opportunity to provide much more detail for this very disruptive condition that she was seemed to be stuck with. The reporter gave permission to contact. Additional Supportive Information: Neuropathic itching was reported as indication but conservatively captured as event and product end date was reported as 17th November 2021 in source document it was not captured as information was not clear. Clarification has been raised.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 01-MAR-2016, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2016, the patient was treated for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Wheezing. Tight chest. Bloodshot eye. Itchy eyes. Pain in eyes. Eye discharge. Eyes swollen.  Eyes red. Redness. Vomiting. Nausea. Ache. Productive cough. This non serious case was received on 24 February 2009 from VAERS (reference number 330523) via a search of QSCAN database. A 39 year old female patient received FLUZONE SV 2008-2009 intramuscularly (lot number U2762AA) on 22 October 2008 at 1:45 pm. The patient began feeling wheezy and had a tight chest at 3:00 pm. Temperature was 97.5. The patient did not have any shortness of breath and was able to continue normal activities. By 5:00 pm her eyes became extremely bloodshot, itchy, painful, and mucus filled. When pressing on her eyelids she noted copious amounts of yellow mucus. Her eyes became painful, swollen, and red. Her nose became red and she developed a productive cough. She took BENADRYL 25 mg and her symptoms became manageable. That night she had an episode of nausea and vomiting, and was achy. The next day she woke feeling better and had no signs or symptoms. The patient recovered.
Severe sore throat and nose stuffiness, Petechia on legs. Did blood test and sent home with antibiotics. On 8/20/2016 Platelets dropped to 9,000 and I was admitted into the hospital with severe immune problems.
Started with a headache, chills.  Evolved into sore arm, fever 101.8 degrees on Sunday.  I could not get out of bed to take my temperature on Saturday but I imagine it was the same if not higher.  I went to bed on Saturday at 4:30 p.m.  with an upset stomach, fever with chills, headache, sore arm and did not get up until Sunday morning at 8:30 a.m.  I did not eat at on Saturday.  I was able to eat a PB&J sandwich.  On Sunday after an hour of being up I went to bed with fever, chills, upset stomach and sore arm but not as severe.  This morning, Monday, I started the morning slow the way it feels when on the end of a flu.  I was back to normal by 1 p.m.
Had COVID-19 in Mar2020. At the time of the vaccine, I felt like the pain from the injection fluid went into my back, on left of my lower back. I was really sick with the pain for 2 months. Took over the counter meds. Herniated disk in left side on my lower back - Felt better after 3 months. Now having sciatic nerve problems. Inject pain killers last week.
Child reported fainting after last vaccine. Child received Tdap and Varicella vaccine and was watched for approx. 10 minutes, child displayed no problems and left clinic. Child fainted in parking lot when leaving. Hit back of head, right side on asphalt producing a plumb size knot with no laceration or bleeding. Child was observed for another 45 minutes with vitals every 15 minutes with no problems, then allowed to go home. Family member was told to watch for the next few hours due to knot on back of head and to notify nurse if any further problems
itching; redness; sore at injection site; hard knot/raised/bumpy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (sore at injection site), VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site) and VACCINATION SITE PRURITUS (itching) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included OLMESARTAN and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (sore at injection site) and VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site). On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching). On 16-Mar-2021, VACCINATION SITE ERYTHEMA (redness) had resolved. At the time of the report, VACCINATION SITE PAIN (sore at injection site), VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site) and VACCINATION SITE PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No laboratory details were  provided.  No treatment medications were reported.
Developed lip swelling, mouth numbness/tingling, dizziness, and difficulty breathing within 30 minutes of receiving the vaccine. In light of the lip swelling (angioedema), she was given Benadryl and epipen at the clinic and transferred to ED for further evaluation. She received Solumedrol and Pepcid. Discharged on prednisone Pepcid, and Allegra, after about 2 hours of observation in ED with gradual decrease in swelling of her lips. No shortness of breath at discharge.
The evening of the 9th day since receiving the Moderna Covid-19 vaccine, I felt body aches and was very tired and lethargic. The injection site and area around it (on my left arm) was swollen and was inflamed. My skin area about 4 inches around the injection site was reddish and firm to the touch. I didn't have these symptoms when I initially received the vaccine. At that time, I only had slight soreness of the arm.
REPORTED NAUSEA, VOMITING, HEADACHE AND PAIN IN THE LEFT ARM RADIATING TO THE SHOULDER AND NECK. REPORTED TROUBLE MOVING HER ARM. REFERRED TO OCCUPATIONAL HEALTH FOR EVALUATION/FOLLOW UP.
Sick; Major Migraine; blood pressure up to around 210 I believe or little higher than that they couldn't stabilized it; heart was propagating; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received BNT162B2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient reported that unfortunately had been in the hospital for 3 days. The patient had taken the first vaccination shot on an unspecified date (reported as "Friday around 1 o'clock") and 5 minutes later, on an unspecified date, patient got really sick and got transferred to the emergency and had to stay there for 3 days. Patient stated that heart was propagating and had to take nitroglycerine 3 times. The patient's blood pressure (unknown date): up to around 210 or little higher than that they couldn't stabilized it like this. Patient had a major migraine, so bad like head was gonna burst. So, patient asked the doctor at the emergency if still needed to take the second shot. They told the patient that would have to talk to patient's general doctor. General doctor was not sure and suggested to call Pfizer because patient had a bad reaction. The patient was hospitalized due to the events. Outcome of the events were unknown.   Information on the lot/batch number has been requested.
Patient's reaction(s) noted during COVID vaccine observation period:   At 1700, patient had left observation area, gotten to car, drove away but returned because she was experiencing nausea and headache. Patient was seated, used wet cloth to forehead and back of neck. VS: B/P 127/86, HR 98, O2 sat 98%, Temp 98.0. At 1715 VS: B/P 124/76, HR 88, O2 sat 98%, temp 98.1. At 1730 VS: B/P 121/91, Hr 86, O2 sat 98%,. Still c/o headache, refused tylenol. Nausea still present but slightly improved.  Reassured by staff and husband and taking sips of Sprite 1745 B/P 118/64, HR 85, )2 sat 98%, nausea improving still has H/A, states these symptoms have occurred in past with other events. 1800 B/P 117/69, HR 89, O2 sat 98%. Was walked out to car, denies lightheadedness or shortness of breath. States other symptoms are improving. Disposition: Declined going to ED. Left to go home with no further concerns.
Tired, achy, headache, neck hurts, nausea, stomach cramps, temp of 95.9, sweating. 1st time receiving flu shot.
Has been having high blood pressure, with the highest at 144/104, and she states that it tends to fluctuate between high and low. She noticed this after having a left-sided severe headache around 5:00 AM on 3/20/2022.
Redness, induration about inj. site.  Feeling bad & little fever onset 24hr after inj.  Next day induration 2" wide, 101 degree temp & aching in entire upper body.  Tylenol & cold compresses helped some.  Next day symptoms still there except generally feeling better.  Today (5 days after inj) all symptoms gone except for achiness in arm.  States last Td in 1995 caused same symptoms, but was much, much less severe.
Narrative:  Patient reported immediate tingling to his left arm and hand where the vaccine was given and a headache. He was monitored for 25 minutes. He reported improvement. He was advised to follow-up with his PCC if the symptoms persist longer than 3 days. He expressed understanding.
I do have thrombocytopenia that was down on a CBC; I might be in remission for 3 years and it suddenly ended up coming back; I have been diagnosed with it in the past and I do not know if that has been flared up but I do have thrombocytopenia that was down on a CBC; This is a spontaneous report from a contactable consumer (patient, self-reporting). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number and expiration dates were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included thrombocytopenia from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient has been diagnosed with it in the past and patient do not know if that has been flared up but patient do have thrombocytopenia that was down on a CBC but doubt this for years like said that was why it might not be a side effect; it might be in remission for 3 years and it suddenly ended up coming back. Patient was perfectly fine and counts were in comfortable number. Patient see haematologist every 6 weeks anyway was back on blood work within few days. It was nothing bad, just wanted to report any kind of information that patient can help with more than willing to give you guys. patient thank god for this vaccine, it was being a life saviour for everybody and so was just trying to help basically. The patient underwent lab tests and procedures which included full blood count: CBC on unspecified date. The outcome of the events was unknown.   In response to further probing, consumer stated, "I am more than willing to do that, you are breaking up again." Consumer hung up the call abruptly, hence, product details (LOT, expiration date, NDC and UPC) and other details were unknown. Limited information was available over the call.  No follow-up attempts needed, information about lot number cannot be obtained.
Information has been received from a RN concerning a Hispanic male, who as a child was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). The pt stated that his mother told him that he had an adverse reaction to the vaccine when he was a child. Additional information has been requested. It was noted that the pt had an experience following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) when he was 38 years old.
swelling, redness, soreness @ site;12cm hard & hot to touch;seen on 27OCT95;
Received vaccine on 03/05/21, by the 10th was having itching,  just under the skin, tried Benedryl and Cortisone cream for a few days, by  the 15th notices whelps on the insides of upper arms, continued self treatment ?till the 17th and couldn?t stand it any longer, was getting no sleep with the itching.  Local ?walk in clinic? as advised by clinic.  Was prescribed steroids.  10mg Prednisone, 4x for 2 days, 3x for 2 days, 2x for 2 days, 1x for 2 days.  Cleared ?whelps? but still a bit itchy.
Freezing; Horrible body aches; Major headache; Nausea; Administration date 28Oct2021, dose number=3; This is a spontaneous report from a contactable consumer, Pfizer colleague. A non-pregnant female patient of unspecified age received the third dose of BNT162b2 (COMIRNATY; Lot Number: Unknown) via an intramuscular route of administration in the arm on 28Oct2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient received any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an intramuscular route of administration on an unknown date and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an intramuscular route of administration on an unknown date as a single dose for COVID-19 immunisation. On 28Oct2021, the patient had "administration date 28Oct2021, dose number=3". On 29Oct2021, the patient woke up the following day "freezing, had "horrible body aches" and a "major headache." She also had nausea. She took ibuprofen (ADVIL) 800mg went to bed then woke up about an hour later feeling better. The events freezing, horrible body aches, major headache and nausea did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events freezing, horrible body aches, major headache and nausea which included treatment with ibuprofen (ADVIL) 800mg. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events freezing, horrible body aches, major headache and nausea was resolved on 29Oct2021. The clinical outcome of the event "administration date 28Oct2021, dose number=3" was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Child received a proquad which contains varicella as well as a separate varicella vaccine same day. This resulted in a double dose of Varicells. Proquad was intended to be a MMR but was given as Proquad by mistake.
This spontaneous report as received from a healthcare worker refers to a 4 year old patient of unknown gender. No information regarding the patient's medical history and concurrent conditions was provided. On 19-NOV-2015, the patient was vaccinated with improperly stored VARIVAX lot # L024256, expiration date: 01-JUL-2017, (exact dose, route of administration and injection site were not reported). There were no concomitant medications reported. It was stated that the vaccine underwent a temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Digital Data Logger (DDL) was used to capture the excursion. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
face felt like plastic; Acute pain in base/spine of neck; dizziness; difficulty breathing & swallowing; difficulty breathing & swallowing; nausea; metallic taste in mouth; double vision; This is a spontaneous report from a contactable consumer.   A 49-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in left arm on 18Mar2021 at 08:15 (Batch/Lot Number: EP7534) as a single dose at the age of 49, for Covid-19 immunisation. Medical history included juvenile- als, and a sulfa allergy. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 18Mar2021, after use of product patient developed Acute pain in base/spine of neck, dizziness, difficulty breathing & swallowing, nausea, metallic taste in mouth, face felt like plastic, double vision. The patient was not hospitalized nor was treatment received for the events. The outcome of the events was recovered. Prior to vaccination, the patient was not diagnosed with COVID 19. Since the vaccination, the patient has not been tested for COVID 19.  Additional Information has been requested.
COVID Test conducted for traveling purposes.  Individual tested positive for COVID-19 on 3/28/2021.
not yet received second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose a year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided are as follows: The age at vaccination was not applicable. Pharmacist reported that till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter had no written record of the exact date of the 1st dose administration, nor any additional information. No further events were reported. The reporter consented to follow-up.
QUARTER-SIZED LUMP AT SITE OF VACCINE ADMINISTRATION. MINOR ITCHING.
Information has been received from a Nurse Practitioner concerning a 26 year old female with an allergy to codeine who on 27-JUL-2007 was vaccinated IM with the first dose of Gardasil (Lot #0211U).  Concomitant therapy included hormonal contraceptives (unspecified).  On 27-JUL-2007 within hours post vaccination the patient experienced a sore throat, a fever (103F), cough and difficulty breathing.  On 30-JUL-2007 the patient sought medical attention and was seen in the physician's office.  At that time her temperature was 99F and her throat was erythematous.  A throat culture was performed, however the results were not reported.  The patient was prescribed Zithromax.  Subsequently, on an unspecified date the patient recovered from the events.  Additional information has been requested.
Arm weakness leg weakness chest pain walk only by use of walker-began 6-8 hrs. after shot. Went to hospital with heart attack (A Fib). Spent 5 days in the hospital.
Day after first dose, had muscle aches and joint pain. Legs felt very heavy and weak. Not tired, no headache. Few days later, started to have pins/needles in hands and feet. Goes away when shift positions. Had worst headache at the end of July. Stood out from other headaches. Felt like someone repeatedly taking a hammer to my head. Headache gone the next day. During this time, since the 1st dose, I have continued to have muscle pain. Joint pain has subsided. Muscle pain the first week after the shot felt like I was on the verge of a charley horse that never actually happened. That subsided a bit to more moderate muscle pain that has continued on and off to this very day. Mostly cramping in calf muscles and hamstrings feel incredibly tight. Calves feel likeI have 2-3 pound weights attached to them. Still getting pins and needles more frequently than I ever remember prior to getting the vaccine. Important to note, that I am still able to exercise. It hasn't stopped my exercise routine, but it has limited my range of motion and what I can I can do to a degree.
her second dose was late; This case was reported by a consumer via call center representative and described the occurrence of product supply issue in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 3 to 4 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The patient stated that, she got her Shingrix vaccinations about 3 to 4 years ago from the date of reporting, unsure of the exact dates. At the 2nd dose of Shingrix, none of the pharmacies had Shingrix in stock and therefore her second dose was late.  The patient would locate her records to see if she could find the dates of the vaccinations and call back with follow up information.  The patient called to inquire if there was a third dose needed or booster for Shingrix.  The reporter did not consent to follow-up.
The 1st dose was on May 2, 2021, bleeding started on day 3, I thought it was my period, but it was different, scarce, and so I spent almost 3 weeks spotting, and on May 24, I started a "normal" bleeding. Which on June 30 (the day I had the 2nd Moderna vaccination) is supposed to stop the bleeding and it seemed that way. But on June 1 when I got up, the bleeding returned more profuse, until today June 2 continues and does not seem to stop. And everything happened to me after the vaccines. I don't know if it has anything to do with it. And I have not been able to see any gynecologist because everything is by appointment and the closest appointments are for November or December. And they don't see it as something of an emergency or priority. And I worry about my hemoglobin. Although for the rest I feel normal.